Jean François Rossi
Jean-François Rossi is Professor of Hematology since 1993. He previously was medical oncologist in the Cancer Center of Montpellier from 1987 and became head of the Hematology Department from 1994 to 2012 at the University Hospital of Montpellier, France. He is now consultant at the University Hospital of Montpellier and at the University Hospital of Nîmes, and was associate professor at Suzhou University (China). Professor Rossi obtained his medical degree and his PhD from the University of Montpellier. He also untertook post-doctoral work at the Cancer Center in Tucson (BGM Durie), at the VUMC San Antonio (GR Mundy) and at the NCI (SA Rosenberg). Professor Rossi was certificated in Rhumatology, Immunology, Medical Oncology, and Hematology. He developed translational research (INSERM U1040, Instiitute of Biotherapy, professor Bernard Klein), particularly targeted therapy, immune therapy for B-cell malignancies, including anti-interleukin 6, anti-BAFF-APRIL anti-HB-EGF therapy, anti-CD20 modulation, cellular therapy, i.e., dendritic cells, T and activated/amplified NK cells from umbilical cord blood with new technology, and identifying active subpopulations (Martin Villalba, INSERM and EEC network CliNK). Professor Rossi is implicated in different scientific advisory boards from innovative start-up companies (BETAINNOV, ORIBASE PHARMA and URODELIA). With BETAINNOV, he participates to new immune functions through the MHC I complex in both dysimmune diseases and hematological malignancies.
Professor Rossi is member of the American Society of Hematology, American Society of Clinical Oncology, European Bone Marrow Transplantation and was member of the American Society of Bone and Mineral Research. He is member of the Castleman Disease Collaborative Network (CDCN) scientific advisory board.
Professor Rossi has published more than 189 peer-viewed articles in the field of immune therapy, identification of new biological targets in cancer, particularly in B-cell malignancies, in different hematology, immunology and cancer journals. He also serves as reviewer for different jounals in this field of research., France